97296 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Anti-KIR3D antibodies
#3302KIR-binding agents and methods of use thereof
#3303Anti-CDH6 antibody drug conjugates
#3304Antibody against human NRG1 protein
#3305Antibody constructs for influenza M2 and CD3
#3306CD3 binding domains
#3307Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6
#3308Monoclonal antibody for antagonizing and inhibiting binding of vascular endothelial growth factor to its receptor, and coding sequence
#3309Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
#3310Antibody constructs for CDH19 and CD3
#3311Antibodies specific to a novel epitope on CεMX of human membrane-bound IgE and uses thereof in treating IgE-mediated diseases
#3312HER3 specific monoclonal antibodies for diagnostic and therapeutic use
#3313THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS
#3314METHODS AND PHARMACEUTICALS COMPOSITIONS FOR TREATING BREAST CANCERS
#3315Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#3316Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
#3317Therapeutic DLL4 binding proteins
#3318Humanized antibodies that bind LGR5
#3319Method of treatment with antibodies having specificity for human OX40
#3320cKIT antibody drug conjugates
#3321Proteins specific for BAFF and B7RP1 and uses thereof
#3322Anti-CD52 antibodies
#3323LLT-1 antibodies with new functional properties
#3324Methods of modulating immune function
#3325Compositions and methods for treating angiogenesis-related disorders
#3326BISPECIFIC ANTIBODIES AND USES THEREOF
#3327Spermidine/Spermine N1 - Acetyltransferase Antibodies As Anti-Cancer Drug Compounds
#3328Non-Antagonistic EGFR-Binding Molecules and Immunoconjugates Thereof
#3329CD20-binding immunotoxins for inducing cellular internalization and methods using same
#3330Antibody fragments, compositions and uses thereof
#3331Anti-B7-H4 antibodies and immunoconjugates
#3332Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
#3333COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER
#3334COMPOSITIONS AND METHODS FOR DETECTING OR ELIMINATING SENESCENT CELLS TO DIAGNOSE OR TREAT DISEASE
#3335Method for treating a disease originated from receptor activation by EREG and TGFα
#3336ANTI-CD22 ANTIBODY-DRUG CONJUGATES AND METHODS OF USING THEREOF
#3337Photosensitizing antibody-fluorophore conjugates
#3338Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereof
#3339M-CSF specific monoclonal antibody and uses therof
#3340Compositions and methods for inducing apoptosis
#3341Endoglin antibodies
#3342Modified toxins
#3343Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancer
#3344Coiled coil and/or tether containing protein complexes and uses thereof
#3345Anti-RSPO2 antibodies and uses thereof
#3346Anti-HER3 antibodies binding to the beta-hairpin of HER3
#3347Therapeutic use of anti-CS1 antibodies
#3348Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions
#3349Bispecific CD33 and CD3 binding proteins
#3350Caninized anti-NGF antibodies and their use
#3351Antibodies against TM4SF5 and methods of use thereof
#3352Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells
#3353BIOMARKERS OF AUTOIMMUNE AND/OR CHRONIC DISEASES ASSOCIATED WITH JOINT INFLAMMATION
#3354Methods of producing antibodies specific for p95
#3355Anti c-Met antibodies
#3356Anti c-Met antibodies
#3357Cell penetrating nucleolytic antibody based cancer therapy
#3358Anti-NTB-A antibodies and related compositions and methods
#3359Treatment of peripheral T cell lymphoma
#3360Human antibodies to serum resistance-associated protein from trypanosoma brucei rhodesiense
#3361Combination therapy involving antibodies against Claudin 18.2 for treatment of pancreatic adenocarcinoma
#3362TUMOR SPECIFIC ANTIBODIES AND USES THEREFOR
#3363Anti-Podoplanin Antibodies and Methods of Use
#3364Antibody constructs for CDH19 and CD3
#3365Human monoclonal antibodies specific for glypican-3 and use thereof
#3366Anti-TAT226 antibodies and immunoconjugates
#3367Methods for expansion or depletion of T-regulatory cells
#3368MFAP4 binding antibodies blocking the interaction between MFAP4 and integrin receptors
#3369Methods of treating, preventing and diagnosing leukemia and other blood diseases and disorders
#3370Diagnosis of a neurological disease
#3371Human monoclonal antibodies to ganglioside GD2
#3372Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#3373Humanized monoclonal antibodies against the extracellular domain of human death receptor 5
#3374Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#3375BCMA antigen binding proteins
#3376Humanized anti-CD22 antibody
#3377Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
#3378Anti-TNF-alpha glycoantibodies and uses thereof
#3379Antibody recognizing folate receptors α and β
#3380Methods of making and using chemically self assembled-nanorings
#3381Antibody Fc mutants with ablated effector functions
#3382Anti-CD324 monoclonal antibodies and uses thereof
#3383Anti-EGFR antibodies and uses thereof
#3384Anti-EGFR antibodies and antibody drug conjugates
#3385Antibodies which bind to epithelial membrane protein 2 (EMP2)
#3386DEPLETION OF IL23R EXPRESSING CELLS IN THE TREATMENT OF VARIOUS DISEASES
#3387Liquid formulations for an anti-TNF α antibody
#3388Ang2 antibodies
#3389Anti-cMet/anti-EGFR/anti-HER3 multispecific antibodies and use thereof
#3390Anti-HER2 antibody and anti-c-Met/anti-HER2 bispecific antibodies comprising the same
#3391Recombinant human IgM-antibody effective against cancer cells
#3392Antibodies targeting CDH19 for melanoma
#3393Therapeutic use of antibodies to HGF
#3394MDR specific antibody
#3395ANTIBODY DRUG CONJUGATES
#3396Anti-PTK7 antibody-drug conjugates
#3397Multispecific antibodies
#3398Antibody to genetic products differentially expressed in tumors and the use thereof
#3399Anti-Glypican-3 Antibody Having Improved Kinetics in Plasma
#3400Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same
#3401Anti-human B7-H4 antibodies and their uses
#3402Anti-PD1 antibodies and their use as therapeutics and diagnostics
#3403Anti-CD79B antibodies and immunoconjugates and methods of use
#3404LINKER-PAYLOAD MOLECULE CONJUGATES
#3405Bispecific antibodies that bind to CD38 and CD3
#3406Anti-CD98 antibody processes
#3407Biological materials related to c-Met
#3408Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins
#3409Stem cell enhancing therapeutics
#3410Nucleic acid molecules encoding anti-CD27 antibodies
#3411Fully human antibodies and fragments recognizing human c-Met
#3412Anti-blood dendritic cell antigen 2 antibodies and uses thereof
#3413Compositions monovalent for CD28 binding and methods of use
#3414METHOD OF TREATING CANCER
#3415Binding proteins comprising at least two repeat domains against HER2
#3416Treatment of angiogenesis disorders
#3417Methods and products for preventing and/or treating metastatic cancer
#3418Antibody capable of specifically recognizing transferrin receptor
#3419Cancer diagnosis and treatment of cancer using anti-ROBO1 antibody
#3420Immunoproteases
#3421Methods for cancer management targeting Co-029
#3422Antibodies to surface determinants
#3423Combination of anti-CD20 antibody and PI3 kinase selective inhibitor
#3424Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma
#3425GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy
#3426Method for treatment of blood tumor using anti-TIM-3 antibody
#3427Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
#3428Bispecific HER2 ligands for cancer therapy
#3429Antibodies to TGF-β
#3430Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
#3431Anti-ADAM28 antibody for treating cancer
#3432Antibodies to non-functional P2X7 receptor
#3433Mesothelin antibodies and methods for eliciting potent antitumor activity
#3434Human monoclonal anti-PD-L1 antibodies and methods of use
#3435Recombinant bispecific antibody binding to CD20 and CD95
#3436DAC HYP compositions and methods
#3437Antibodies against human CSF-1R and uses thereof
#3438Antibodies against human CSF-1R and uses thereof
#3439Compositions and methods relating to anti-IGF-1 receptor antibodies
#3440Human anti-human epidermal growth factor receptor antibody and encoding gene and application thereof
#3441Recombinant TNF ligand family member polypeptides with antibody binding domain and uses therefor
#3442ANTAGONIST ANTIBODY FOR THE TREATMENT OF CANCER
#3443Stable and soluble antibodies inhibiting VEGF
#3444Compounds and methods for treating pain
#3445SUPERIOR EFFICACY OF CD37 ANTIBODIES IN CLL BLOOD SAMPLES
#3446Methods and antibody compositions for tumor treatment
#3447Antibodies to CD70
#3448Therapies based on control of regulatory T cell stability and function via a neuropilin-1:semaphorin axis
#3449IL-21 antibodies and methods of making or using the antibodies
#3450Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
#3451Method of inhibiting or treating cancer metastasis
#3452CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
#3453Anti-BLyS antibody
#3454Anti-Jagged1 antibodies and methods of use
#3455In vitro generation of dendritic cells by exposure to an anti-CSF1-R antibody
#3456ANTI-ErbB2 ANTIBODIES
#3457Monoclonal antibodies against claudin-18 for treatment of cancer
#3458Monoclonal antibodies against claudin-18 for treatment of cancer
#3459TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND VK REGIONS AND ANTIBODIES PRODUCED THEREFROM
#3460JAM-C antibodies and methods for treatment of cancer
#3461Human domain antibodies against components of the human insulin-like growth factor (IGF) system
#3462Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
#3463ANTIBODY FC VARIANTS
#3464Antibodies directed against ICOS for treating graft-versus-host disease
#3465Anti-EGFR/anti-HER2 bispecific antibodies with anti-EGFR DARPins
#3466Methods of Treating Hematological Malignancies with Notch1 Antibodies
#3467Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
#3468CD3 binding polypeptides
#3469ANTIGEN-BINDING MOLECULE AND USES THEREOF
#3470Method for regulating cell proliferation
#3471Modulation of the immune response
#3472Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin
#3473Antibodies to non-functional oligomeric P2X7 receptors and methods of use thereof
#3474Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
#3475Combination therapy using bispecific anti-c-Met/anti-EGFR antibody and c-Src inhibitor
#3476Biomarker TFF1 for predicting effect of C-MET inhibitor
#3477Macromolecular compositions that cross the blood-brain barrier and methods of use thereof
#3478DAC HYP compositions and methods
#3479Anti-Siglec-8 antibodies and methods of use thereof
#3480Monoclonal antibody against human midkine
#3481α/β-peptide mimics of Z-domain peptides
#3482DAC HYP compositions and methods
#3483Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19
#3484Method of treating cancer by administering a monoclonal antibody that binds human NOTCH2 and NOTCH3
#3485Anti-plasmodium parasite antibodies
#3486Jagged-binding agents and uses thereof
#3487Anti-ETBR antibodies and immunoconjugates
#3488Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
#3489Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
#3490Alpha-enolase specific antibodies and methods of uses in cancer therapy
#3491Anti-ETBR antibodies and immunoconjugates
#3492Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#3493Methods of treating GVHD and transplant rejection with anti-PSGL-1 antibodies
#3494Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#3495Multifunctional antibodies binding to EGFR and MET
#3496OVR110 ANTIBODY COMPOSITIONS AND METHODS OF USE
#3497Deimmunized serum-binding domains and their use in extending serum half-life
#3498IL-3 antibodies and their use in diagnosis and treatment of diseases or malfunctions associated with elevated levels of IL-3
#3499Monoclonal antibodies for treatment of cancer
#3500Notch1 receptor binding agents and methods of use thereof
#3501Cytotoxic immunoglobulin
#3502NOVEL THERAPEUTIC TREATMENTS WITH ANTI-HER2 ANTIBODIES HAVING A LOW FUCOSYLATION
#3503Anti-CD3 antibodies and methods of use
#3504Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
#3505CYSTEINE ENGINEERED ANTI-TENB2 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
#3506Antibodies against human CSF-1R and uses thereof
#3507Gremlin-1 antibody
#3508HIV antigens and antibodies and compositions, uses and methods thereof
#3509Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
#3510Anti-C-Met/anti-Ang2 bispecific antibody
#3511PD-1 specific antibodies and uses thereof
#3512Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2
#3513BTLA antibodies and uses thereof
#3514Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody
#3515High-affinity monoclonal antibodies to glypican-3 and use thereof
#3516Compositions and methods for targeting type 1 interferon producing cells
#3517CD33 antibodies and use of same to treat cancer
#3518Antibody against transporter and use thereof
#3519Anti-αβantibodies
#3520Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers
#3521Compositions and Methods for Regulating CAR T Cells
#3522IL-6 binding molecules
#3523Methods of treating tumors with engineered antibody-interferon mutant fusion molecules
#3524Immunogenic compositions of antigens
#3525Methods and compositions for treating neuroblastoma
#3526Bispecific antibodies against human TWEAK and human IL17 and uses thereof
#3527Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers
#3528Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides
#3529Disease therapy by inducing immune response to Trop-2 expressing cells
#3530Anti-human IL-23 receptor antibody and encoding polynucleotides
#3531In vitro culture conditions for T-cell acute lymphoblastic leukemia/lymphoma
#3532Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
#3533Substance specific to human PD-1
#3534Antibody Fc mutants with ablated effector functions
#3535Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
#3536Antibodies or antigen-binding fragments thereof specifically binding to VEGF-C and use thereof
#3537Cysteine engineered fibronectin type III domain binding molecules
#3538Anti-ErbB2 antibody variants
#3539Anti-αβTCR antibody
#3540VEGF binding antibodies
#3541Monoclonal Olfml-3 antibodies and uses thereof
#3542Protein constructs designed for targeting and lysis of cells
#3543Anti-fXI antibodies and methods of use
#3544Multi-functional antibody polypeptide for cryptic epitope of epidermal growth factor receptor and T cell antigen
#3545Immunopotentiative composition
#3546Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereof
#3547Antibodies that specifically bind to TIM3
#3548Anti-VEGF antibodies
#3549Anti-mIgE antibodies that bind to the junction between CH4 and CεmX domains
#3550Humanized pan-HER antibody compositions
#3551Methods for binding members of interleukin-4 receptor α (IL-4Rα)
#3552Multispecific antibodies, multispecific activatable antibodies and methods of using the same
#3553Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
#3554LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same
#3555Combination therapy using c-Met inhibitor and beta-catenin inhibitor
#3556Anti-NKG2A antibodies and uses thereof
#3557Anti-HER2 and anti-IGF-IR BI-specific antibodies and uses thereof
#3558Polyvalent chimeric OSPC vaccinogen and diagnostic antigen
#3559ANTICANCER AGENT
#3560Enhancing immunity to tuberculosis
#3561Antibodies to tumor endothelial marker 7R
#3562Anti-CD40 antibody mutants
#3563Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside
#3564Anti-PRLR antibodies and methods for killing PRLR-expressing cells
#3565Anti-PRLR antibodies and methods for killing PRLR-expressing cells
#3566Monoclonal antibodies that bind B7H6 and uses thereof
#3567The IgM and IgE Heavy Chain Domain 2 as Covalently Linked Homodimerization Modules for the Generation of Fusion Proteins with Dual Specificity
#3568Chimeric antigen receptors targeting B-cell maturation antigen
#3569Methods for diagnosing and treating neuroendocrine cancer
#3570Anti-CXCL13 antibodies and methods of using the same
#3571Anti-NGF antibodies and methods using same
#3572High affinity antibodies that neutralize enterotoxin B
#3573AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIES
#3574Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#3575Binding molecules with antitumoral activity
#3576Nucleic acids encoding anti-Siglec-15 antibodies
#3577Anti-phospholipase D4 antibody
#3578Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases
#3579MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS
#3580Antibodies that specifically bind to the EphA2 receptor
#3581Methods of treating autoimmune diseases
#3582Compositions, methods and kits for treatment of cancer and autoimmune diseases
#3583ANTIBODIES OR FUSION PROTEINS MULTIMERIZED VIA HOMOMULTIMERIZING PEPTIDE
#3584TREATMENT DRUG FOR AUTOIMMUNE DISEASES AND ALLERGIC DISEASES
#3585Antigen binding protein and its use as addressing product for the treatment of cancer
#3586Anti-CXCR4 antibodies and antibody-drug conjugates
#3587Methods and compositions for inhibiting CD32B expressing cells
#3588Methods and compositions for inhibiting CD32b expressing cells
#3589IL-1β neutralizing human monoclonal antibodies
#3590POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF
#3591Anti-EGFR antibody and anti-c-Met/anti-EGFR bispecific antibodies comprising the same
#3592Bispecific chimeric proteins comprising DARPins
#3593Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors
#3594Binding molecules for BCMA and CD3
#3595Fusion polypeptide inhibiting VEGF-C, VEGF-D and/or angiopoietin-2, and use thereof
#3596Anti-epithelial cell adhesion molecule (EpCAM) antibodies and methods of use thereof
#3597Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
#3598Combinations and uses thereof
#3599HER3 inhibitor for modulating radiosensitivity
#3600Anti-IGF antibodies